BioBuzz Regional Roundup| Greater Philadelphia | March 28, 2025

BioBuzz Media

Mar 31, 2025 - 09:08

BioBuzz Regional Roundup| Greater Philadelphia | March 28, 2025

BioBuzz | Greater Philadelphia | March 28, 2025

Philadelphia’s life sciences sector saw major strides this week, from strong financial reports to groundbreaking research at The Wistar Institute. Key leadership moves signal continued growth and a reason for optimism. With funding wins, clinical breakthroughs, and executive shifts, Philly remains a powerhouse for biotech innovation. Read on for our top stories shaping the industry!

Bryan Kennedy + Owen Buzy

BioBuzz Networks | Greater Philadelphia

philadelphia@biobuzz.io

FINANCIAL

Annovis: Corporate Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results More
Windtree Therapeutics: Regains Compliance With Nasdaq Listing Rules More
CEPI: New Funding for Vaccine to Protect Against Deadly MERS Coronavirus More
Children's Hospital of Philadelphia: Researchers Awarded $1.3M From Eagles Autism Foundation More
NEXGEL: Record Fourth Quarter and Full Year 2024 Financial Results More
Savara: Enters Into Non-Dilutive Debt Financing for up to $200M With Hercules Capital More
Altaris: Acquires Advanced Therapies More
Kardigan: Acquires Prolaio to Create a Pioneering Heart Health Company With One-of-a-Kind Integrated Cardiovascular Data and Therapeutics Platform More
Annovis Bio: Receives Continued Listing Standard Notice From the NYSE More

CLINICAL & COMMERCIAL

Opthea: COAST Phase 3 Trial Topline Results More
The Wistar Institute: Scientists Demonstrate Pre-clinical Proof of Concept for Next-Gen DNA Delivery Technology More
Traws Pharma: Antiviral Bird Flu Program, Tivoxavir Marboxil, Shows Positive Data in Non-human Primates More
Soligenix: Publication Demonstrating CiVax Booster Induces Rapid Broad Protection Against COVID-19 Variants More
Savara: Completes Submission of the Biologics License Application to the U.S. Food and Drug Administration for MOLBREEVI as a Treatment for Autoimmune Pulmonary Alveolar Proteinosis More
Sonnet BioTherapeutics: Successfully Completes First Safety Review of SON-1010 in Combination With Trabectedin in Certain Sarcomas More
Teleflex: Preliminary Results From IDE Study on Ringer Perfusion Balloon Catheter Reported From Podium at CTO Plus Conference More

WORKFORCE

Harmony Biosciences: Names Adam Zaeske as Chief Commercial Officer to Lead the Next Phase of Commercial Growth as Its Portfolio Expands More
Center for Forensic Science Research: Lays Off 30% of Staff Amid Federal Funding Uncertainty More
Verrica Pharmaceuticals: Appoints Noah L. Rosenberg, M.D., as Chief Medical Officer More
Arbutus: Jettisoning 57% of Staff, Ceasing In-House Research More

JOBS

- iECURE (Philadelphia, PA) - A clinical-stage gene editing company. Check out jobs here>
  - Director, Global Regulatory Affairs
  - Manager, Manufacturing (Upstream)
  - Manager, Manufacturing (Downstream)

Cabaletta Bio (Philadelphia, PA) - A clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies. Check out jobs here>

Director, Clinical Scientist
Senior Director, CMC Regulatory Affairs

Director, Clinical Program Management

BUZZIN' EVENT

Our next event is right around the corner!

BioInnovation Series: AIxBio Philly

Learn More>

JOIN OUR COMMUNITY | HIRE TALENT

Tags:

Seal Hemostatic Wound Spray Gains Approval to be Utilized by Maryland EMS Clinic...

BioBuzz Media BioBuzz is a community led, experience focused, biotech and life sciences media and events company. BioBuzz highlights regional breaking news, industry professionals, jobs, events, and resources for business and career growth. Their weekly newsletter is subscribed to by thousands in the BioHealth Capital Region and Greater Philadelphia as the go-to for industry updates.

BioBuzz Regional Roundup| Greater Philadelphia | March 28, 2025

Tags:

Related Posts

Popular Posts

Follow Us

Recommended Posts

Popular Tags